Private Capital Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2K | Hold |
55
| – | – | ﹤0.01% | 1609 |
|
|
2022
Q1 | $3K | Sell |
55
-17
| -24% | -$927 | ﹤0.01% | 1727 |
|
|
2021
Q4 | $4K | Buy |
72
+8
| +13% | +$444 | ﹤0.01% | 1645 |
|
|
2021
Q3 | $4K | Sell |
64
-48
| -43% | -$3K | ﹤0.01% | 1691 |
|
|
2021
Q2 | $5K | Buy |
112
+54
| +93% | +$2.41K | ﹤0.01% | 1580 |
|
|
2021
Q1 | $2K | Buy |
58
+48
| +480% | +$1.66K | ﹤0.01% | 1809 |
|
|
2020
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1988 |
|
|
2020
Q3 | – | Sell |
-125
| Closed | -$6K | – | 2132 |
|
|
2020
Q2 | $6K | Sell |
125
-33
| -21% | -$1.58K | ﹤0.01% | 1486 |
|
|
2020
Q1 | $7K | Buy |
+158
| New | +$7K | ﹤0.01% | 1408 |
|